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We compared nef gene sequences isolated by polymerase chain reaction from peripheral blood lymphocyte DNA of
macaques that had been inoculated with either biologically (E11S) or molecularly (clone 8) cloned SIV/Mne. Two samples
from each animal obtained either early (weeks 2–8) or late (weeks 21–137) after infection were analyzed. Three substitutions
in the predicted Nef amino acid sequence were seen in all animals at the late time point, and two other substitutions were
seen in all except one. Two of the common exchanges are located ;40 residues apart in the Nef core sequence but are
juxtaposed on the tertiary structure as judged by computer modeling using the structure of the HIV Nef core protein as a
guide. Most recurrent in vivo changes replaced a residue found in the cloned Nef sequence with one present in a consensus
derived by aligning the Nef sequences of the SIV/Sm clade. Recombinant virus containing a macaque-adapted (MA nef) nef
on the clone 8 backbone was 3-fold more infectious on SMAGI cells than the original virus. A lymphocyte line infected with
SIV-clone 8-MAnef contained a large proportion of cells carrying provirus with defective nef genes. These findings suggest
that the nef gene of the cloned SIV/Mne had undergone attenuating mutations during propagation in tissue culture that were
“corrected” in vivo. © 1998 Academic Press
INTRODUCTION
The nef gene is an accessory gene unique to primate
lentiviruses. It overlaps the 39 long terminal repeat (LTR)
and in some virus species also the 39-end of env (Harris,
1996; Michael et al., 1995). It is transcribed early in
infection from multiply spliced RNAs (Kaminchik et al.,
1990), and depending on the virus strain, nef encodes a
myristoylated protein of 25–32 kDa that is located on the
cytoplasmic side of the cell membrane (Guy et al., 1987;
Franchini et al., 1986).
The role of the nef gene in the virus life cycle is still
enigmatic. Early reports showed that a significant pro-
portion of virus isolates contained inactivating mutations
in nef but were found to replicate as efficiently as iso-
lates with apparently intact nef genes, suggesting that
the gene was not needed for replication in tissue culture
cells (Blumberg et al., 1992; Fisher et al., 1986). Indeed,
initial findings suggested that it had a negative effect on
viral replication through downregulation of transcription
from the LTR (Ahmad and Venkatesan, 1988; Luciw et al.,
1987; Luo and Garcia, 1997). In addition, nef was re-
ported to interfere with transcription of other nuclear
factor-kBs, as well as activated protein (AP)-1-regulated
promoters and with interleukin-2 production (Reinhart et
al., 1996; Niederman et al., 1993, 1992; Tokunaga, 1996).
Other reports demonstrated that there was no consistent
negative effect on viral replication but that the viral yield
was critically dependent on the cell line and, in particu-
lar, virus strain used (de Ronde et al., 1992; Kim et al.,
1989; Hammes et al., 1989; Terwilliger et al., 1991). Re-
cently, evidence has been presented that nef affects the
infectivity of viral particles because viruses produced in
the absence of nef show defects in the synthesis of
proviral DNA or in incorporation of env-SU into the par-
ticle (Wiskerchen and Cheng-Mayer, 1996; Pandori et al.,
1996; Chowers et al., 1995).
At the cellular level, Nef has been shown to downregu-
late CD4 by enhancing its turnover rate (Guy et al., 1987;
Garcia and Miller, 1991; Mariani and Skowronski, 1993).
Recent studies have shown an involvement of Nef and
CD4 with the adapter protein AP-1 in clathrin-coated pits,
further elucidating the role of Nef in CD4 downregulation
(Greenberg et al., 1997; Foti et al., 1997). Interference in
the signal transduction system was suggested by its
effect on transcriptional activities. Nef has been reported
to affect and even to interact directly with a plethora of
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components of the signal transduction network of vari-
ous cell types; again, some results from different labo-
ratories contradict each other (review in Luo et al., 1997)).
Most studies of Nef function have been done with Nef
proteins derived from virus isolates propagated in tissue
culture cell lines, and in several instances, strain differ-
ences could be shown to account for some of the incon-
sistencies in the results (Garcia and Foster, 1996). Prop-
agation of virus in tissue culture might lead to attenuated
nef genes as a consequence of genetic drift of a se-
quence that is no longer under the selective pressure
that would be present in vivo. In addition, there is evi-
dence that Nef has a negative effect on cell growth,
which would lead to selection of attenuating mutations:
cells that are forced to express high levels of a marker
linked to nef often acquire inactivating mutations in nef
(Baur et al., 1994; Trono, 1995; Su et al., 1997).
The importance of nef for viral fitness and pathoge-
nicity in vivo has been irrefutably demonstrated: infec-
tion of macaques with a molecularly cloned SIV virus
with a deletion in the nef gene resulted in very low
levels of viremia and no disease for the time interval
tested after infection (Kestler et al., 1991). Similarly,
deletions of nef were found in some long-term survi-
vors of HIV infection (Mariani et al., 1996; Deacon et
al., 1995). Inhibitory point mutations, such as prema-
ture stop codons, acquired in tissue culture, are rap-
idly reverted in vitro, underlining the different selective
pressures exerted on the nef gene in vivo and in vitro
(Kestler et al., 1991). In parallel, the very rapid time
course from infection to time of death of a different
strain of SIV (SIV/sm/Pbj14) could, at least in part, be
attributed to one amino acid substitution in Nef (Du et
al., 1996). Incorporation of this exchange into the SIV/
Mac239 clone resulted in a virus that caused fatal
disease in 7–10 days rather than the normally ob-
served 6–9 months. This latter strain also caused
activation of resting mononuclear cells and trans-
formed NIH 3T3 cells.
The molecular clone of SIV/Mne used in this report
has no obvious inactivating mutations in the nef gene
and was obtained from a single-cell clone of infected Hut
78 cells that produced high levels of infectious virus. We
hypothesized that the virus had acquired attenuating
missense mutations in nef, which should be reverted in
vivo, thus highlighting residues that are important for Nef
function. To test this hypothesis, we analyzed nef se-
quences obtained from macaques that had been inocu-
lated with biologically (single-cell clone) or molecularly
cloned SIV/Mne (Benveniste et al., 1989, 1988). We found
that five Nef residues had undergone consistent substi-
tutions in almost all sequences isolated late in infection
from the animals studied. In addition, other residues
were found to have changed in more than one animal.
The macaque-adapted (MA) nef conferred increased in-
fectivity to the virus, but mutated versions rapidly accu-
mulated in a tissue culture environment.
RESULTS
Biological cloning of SIV/Mne
SIV/Mne was originally isolated on HuT 78 cells from
a lymph node of a pigtailed macaque (Macaca nimest-
rina) that had died from lymphoma in 1982 at the Univer-
sity of Washington Primate Research Center (Benveniste
et al., 1986). SIV/Mne clone E11S is a single-cell clone of
SIV/Mne-infected HuT 78 cells that was obtained by
plating dilutions of infected HuT 78 cells onto a mono-
layer of sheep choriod plexus cells in microtiter plates
(Benveniste et al., 1990). Every HuT 78 cell in clone E11S
is identical and contains two SIV/Mne proviruses inte-
grated at two sites (as shown in this report). While
SIV/Mne E11S causes disease more slowly than un-
cloned virus, it contains large amounts of gp120 enve-
lope glycoprotein and gag proteins in the viral particle
and has been used for the characterization of SIV viral
proteins (Henderson et al., 1988a, 1988b), as well as for
in vivo infectivity studies (Benveniste et al., 1994; Kuller et
al.. 1994) and in various AIDS vaccine studies (Shaffer-
man et al., 1991; Hu et al., 1992; Arthur et al., 1995).
Molecular clones of SIV/Mne
Because all E11S cells are identical and produce in-
fectious and pathogenic virus, this cell line was chosen
as the starting material for molecular cloning. DNA frag-
ments of ;15–20 kb generated by partial digest of high-
molecular-weight genomic DNA with MboI were cloned
into lambda vector EMBL3 (Frischauf et al., 1983). A
library of 106 plaque forming units was screened using
the internal 7-kb fragment of SIV/Mac251 clone as a
probe (Hirsch et al., 1986). Nine clones were isolated and
mapped by restriction analysis, which revealed that they
derived from two different proviruses (Fig. 1). This was
verified by Southern blotting (data not shown). Only clone
8 contained a full-length copy of one provirus. DNA
sequencing determined that all reading frames of clone
8 were open with the exception of env, which carried the
typical premature stop codon at position 8277 seen in
the transmembrane part of the env genes of tissue cul-
ture isolates of SIV (Kestler et al., 1989). The sequence
for SIV/Mne clone 8 was deposited as M32741 in Gen-
Bank. Transfection of clone 8 DNA into HuT 78 cells
resulted in the production of infectious virus (data not
shown). This SIV/Mne clone 8 virus preparation was
used to infect two pigtailed macaques (F87047 and
M87044) intravenously. One animal (F87047) first
showed a decrease in CD41 lymphocytes at 10 months
after infection and was euthanized at 19 months because
of bleeding caused by severe thrombocytopenia (Table
1). The other macaque (M87004) first showed CD4 de-
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pletion at 1 year and was euthanized at 52 months with
Campylobacter lari septicemia (Table 1).
The second provirus present in E11S was reconsti-
tuted from clones 3 and 9 (Fig. 1). Transfection of the
resulting construct into 293 cells yielded virus that was
infectious on CEM and AA2CL5 cells (data not shown).
The sequence of this provirus was determined around
the nef gene between residues 8140 and 9310 and found
to be identical to that of clone 8.
Comparison of Nef sequences from animals
inoculated with cloned SIV/Mne virus
We compared the nef sequence of the SIV/Mne clone
8 with the sequences obtained directly from peripheral
blood mononuclear cells (PBMCs) of macaques infected
intravenously or intrarectally with clone E11S or clone 8
virus. Two species of macaques (M. fascicularis and M.
nemestrina) were used in this study. The dose of virus,
route of infection, time until death after infection, and
principal pathological findings at necropsy are shown in
Table 1. Of the nine macaques examined, seven had
been infected directly with either molecular clone 8- or
clone E11S-derived virus, whereas animal 90076 re-
ceived PBMCs and lymph node cells from another ma-
caque (89152) that had been infected with E11S virus 43
weeks previously. Macaque 92170 was a control animal
in a vaccine study and had been infected with uncloned
virus. All macaques showed CD4 depletion with an av-
erage time to onset of 50 weeks for the animals that had
received clone 8 or clone E11S virus and for which
continuous CD4 data were available. The average time
to death for these animals was 123 weeks (2.4 years). In
contrast, macaques 90076 and 92170 died after 39
weeks and 65 weeks, respectively, and had developed
metastatic lymphosarcoma.
To evaluate the sequence divergence accumulated in
the nef gene during the course of infection, we isolated
genomic DNA from PBMCs obtained shortly after inocu-
lation (2–8 weeks p.i.) and at later times (21–137 weeks
p.i.). All except one of the later time points (92170) were
obtained from animals that were already CD4 depleted.
nef gene sequences were amplified by nested polymer-
ase chain reaction (PCR), starting with 500 ng of DNA
isolated from PBMCs. To determine the frequency of
misincorporation during nested PCR, we sequenced five
clones obtained from independent PCRs using the same
primer sets on DNA isolated from E11S and found one
divergence from the clone 8 sequence (data not shown),
indicating an error rate of 1:3500 nucleotides. Sensitivity
tests using DNA isolated from mixtures of E11S cells with
uninfected HuT 78 cells showed that the detection limit
was 2–5 proviruses in 104 cells.
Pairwise comparison of 58 nef open reading frames
(792 nucleotides) from the animal isolates to the original
clone 8 nef revealed between 1 (0.1%) and 29 (3.3%)
nucleotide substitutions (Fig. 2). Seven sequences had
premature termination codons, one sequence had a
three-nucleotide insertion (90184wk137 sequence 1), one
FIG. 1. Restriction maps of molecular clones 3, 8, and 9. Clones 3 and 9 contain sequences from one of the two proviruses present in cell clone
E11S, whereas clone 8 represents the other provirus. Restriction sites defining the difference between the integration sites of the proviruses are
circled. Shaded boxes represent the left and right arms of the EMBL3 cloning vector. (B) BglII. (Bw) BsiWI. (Bb) BsmBI. (E) EcoNI. (H) HindIII. (S) SacI.
(S1) SalI. (Sc) ScaI. (X) XbaI.
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had a three-nucleotide deletion (90125wk84 sequence 2),
and one had a 13-nucleotide deletion (90125wk8 se-
quence 4). A total of 549 nucleotide differences were
observed; $351 of these had occurred independently in
different animals. Ninety-four percent (518) of the nucle-
otide exchanges resulted in amino acid substitutions
(Fig. 2). Within the 167-nucleotide-long region of overlap
between env and nef, 162 nucleotide substitutions were
found, giving rise to 57 amino acid changes in Env (data
not shown) and 102 in Nef. Only 2 of the changes in Env
were common to two animals, but they also resulted in
sequence alteration in Nef. In contrast, 5 changes in this
region of nef were found in at least two independent
isolates and resulted in amino acid substitutions in Nef
but were silent in Env. One of these common changes is
the A–G transition at nucleotide position 101, which gave
rise to the glutamic acid–to–glycine exchange at position
34 (E34G) and occurred in late isolates from all animals.
The prevalence of recurring changes that resulted in
differences at the protein level in Nef but not in Env
suggests that Nef, rather than Env, function was under
selective pressure.
Nucleotide sequences from early time point sam-
ples differed by 0.1–1.3% from clone 8 nef, whereas late
isolates had diverged by 0.8–3.3%. At the amino acid
level, the differences were 0–4% at early times and
2–8% at late time points (Figs. 2 and 3). Although it is
possible that some of these differences are caused by
PCR artifacts, the number and overall pattern of the
divergences argue that the majority are due to real
divergence in the amplified virus population. Most of
the differences observed early were evenly distributed
throughout the gene and transient (i.e., they either
were observed in only one clone or were not main-
tained in the virus population of a given animal to the
later time point) (Figs. 2 and 3). The exception was the
I111M exchange, which was present in both cases in
which samples had been taken 8 weeks p.i.
In contrast to the random distribution of mutations in
early samples, late isolates contained several amino
acid substitutions that were consistently observed in
most samples: E34G, I87M, and I111M were present in
at least one clone derived from the late sampling of
each animal, and M153I/V and N95D were seen in all
except one (89144) or two (89144, F87047) animals,
respectively (Figs. 2 and 3). No early time point sam-
ples were available for the animals that had been
inoculated with the molecularly cloned virus, but the
TABLE 1
Macaques Used for the Isolation of nef Clones
Animal
#
Macaque
species Inoculum, dose, routea
Date of
challenge
Date of death
(weeks p.i.)
Weeks of
sampling
Pathology (onset), cause
of deathb Study Reference
F87047 M. nemestrina Clone 8, 103 TCID, IV 11/5/87 6/15/89
(wk 83)
81 CD4 depletion (wk 40),
severe
thrombocytopenia
Pathogenicity of
molecular
clone
Rudensey
et al. (1995)
M87004 M. nemestrina Clone 8, 103 TCID, IV 11/5/87 3/3/92
(wk 225)
135 CD4 depletion (wk 52),
anemia, weight loss,
Campylobacter
septicemia
Pathogenicity of
molecular
clone
Rudensey
et al. (1995)
89152 M. fascicularis Clone E11S, 10 TCID
(;10 AID), IV
8/16/90 8/20/92
(wk 104)
2, 65 CD4 depletion, anemia,
wasting
Control animal
in vaccine
study
Hu et al.
(1989, 1993)
90076 M. fascicularis PBMC 1 lymph node
cells from 89152 (wk
43 p.i.)c
6/14/91 3/11/92
(wk 39)
4, 21 Malignant lymphoma Recipient of
cells from
89152
Hu et al.
(1989, 1993)
F90184 M. nemestrina Clone E11S, 104 TCID
(100 AID) IRd
7/17/91 3/24/94
(wk137)
8, 137 CD4 depletion (wk 30)
anemia, wasting
Intrarectal
titration
Clerici et al.
(1994)
89144 M. fascicularis Clone E11S, 20 TCID
(20 AID), IV
8/3/92 11/28/94
(wk 120)
2, 85 CD4 depletion (wk 61)
wasting
Control in
vaccine
study
Hu et al.
(1989)
90125 M. fascicularis Clone E11S, 20 TCID
(20 AID), IV
8/3/92 9/12/94
(wk 110)
8, 84 CD4 depletion (wk 55),
leg paralysis, anemia
Control in
vaccine
study
Hu et al.
(1989)
91419 M. fascicularis Clone E11S, 20 TCID
(20 AID), IV
8/3/92 2/17/94
(wk 80)
4, 71 CD4 depletion (wk 61)
bacteremia
Control in
vaccine
study
Hu et al.
(1989)
92170 M. fascicularis SIV/Mne uncloned,
100 TCID (10 AID),
IV
6/8/93 9/9/94
(wk 65)
4, 31 CD4 depletion (wk 34),
malignant lymphoma
Control in
vaccine
study
a Animals were infected with either molecular clone 8 or biological clone E11S of SIV/Mne as shown. The tissue culture infectious dose (TCID) was
determined with 10-fold serial dilutions on AA-2 cells; the animal infectious dose (AID) is listed when known. IV, intravenous, IR, intrarectal inoculation.
b The most remarkable clinical findings are listed as is the onset of CD4 depletion.
c 2 3 107 inguinal lymph node cells and 2 3 107 PBMC obtained from macaque 89152 at 43 weeks post inoculation (p.i.) were inoculated IV into
this animal.
d The minimal infectious dose required for intrarectal infection is ;103 times greater than the minimum infectious dose after an IV challenge.
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FIG. 2. Comparison of the predicted amino acid sequences for the nef ORFs isolated from animals after infection with cloned virus. The animal
number and week of sampling are given. The amino acid sequence of SIV/Mne clone 8 is shown in single-letter code. Residues that diverge from
the SIV/Sm consensus are shown above the sequence. In the alignment, only amino acids that differ are shown, whereas identities are indicated
(dots). (Exclamation marks) Synonymous changes in a codon. (Dashes) Gaps. The conserved boxes described for HIV/SIV Nef sequences are also
indicated (Shugars et al., 1993). Also indicated is the location of the myristoylation signal. (PPT) Primer binding site is located in the coding sequence
for the Nef protein. (env and LTR) Boundaries for the env gene and the LTR, respectively.
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late time samples show the same pattern of mutations
as the others. In addition to the five most common
substitutions, several other changes were observed in
more than one animal: T5I, G75R, P101S, F122L,
M144I/V, S212T, and R246K (Fig. 2).
Clones from two animals showed different patterns
FIG. 2—Continued
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of divergence; early isolates from animal 90076, which
had been infected with PBMCs and lymph node cells
from macaque 89152 drawn at week 43, already
showed the mutations typical for late isolates and
differed by 1.5–1.9% from the clone 8 nucleotide se-
quence and by 4% in the amino acid sequence. In
addition, all of the early isolates from animal 92170,
which had been infected with uncloned virus, had the
FIG. 2—Continued
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hallmark features of the MA nef gene rather than those
of clone 8 Nef. Sequence analysis of the uncloned
population revealed that most viruses contain a nef
gene similar to the MA nef. We analyzed 15 nef se-
quences of proviral genomes present in the HuT 78/
SIV/Mne culture used to generate the virus stock in-
oculated into this animal. Ten of the genes were inac-
tivated by nonsense or frameshift mutations, and one
was inactivated by a missense mutation that resulted
in loss of the myristoylation site. The majority (14 of 15)
encoded the same residues as the MA nef at positions
34, 87, 95, and 111. Only residue 153 was generally a
methionine as in clone 8 (data not shown).
Biological activities of the MA nef gene
To evaluate whether the mutations in nef present in
MA E11S virus have any biological effect, we incorpo-
rated the nef gene of the third clone of the week 4
sample of animal 90076 into the clone 8 DNA, thus
generating clone 8-MA nef (see Materials and Methods).
This clone carried all the hallmark substitutions of an MA
gene with only three additional changes. The DNA was
transfected into 293 cells, and supernatants were har-
vested after 48 h and used to infect AA2CL5 cells to
generate virus stocks. The stocks were titered using an
antigen capture kit, and equal amounts were used to
infect SMAGI cells. Two independently generated sets of
virus stocks yielded the same result (Table 2), showing
that the virus containing the MA nef gene from 90076
was 3-fold more infectious than clone 8 virus. In addition,
we generated a clone 8 derivative with a deletion in nef
similar to that described by Kestler et al. (1991). This
virus, clone 8 Dnef, was 3- and 6-fold less infectious than
clone 8 and clone 8-MA nef viruses, respectively.
We observed no difference in the ability of clone 8 Nef
and MA Nef to downregulate CD4 from the cell surface.
CEM cells infected with retroviral vector constructs ex-
pressing either clone 8-Nef or MA Nef presented similar
levels of CD4 on their cell surface, which were ;5% of
the level observed in cells infected with retroviral vector
carrying the nef gene in antisense orientation (data not
shown).
FIG. 3. The frequency of substitutions early and late after infection. The number of substitutions at a given position is indicated by the height of
the bar relative to the total number of sequences analyzed at each time point given by the y axis of the graph. All substitutions are scored regardless
of whether they occurred independently. The changes that occurred repeatedly are given in single-letter format.
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The residues in clone 8 that had consistently been
replaced in animals could have accumulated in vitro as a
consequence of genetic drift in a neutral sequence, or
they could be due to negative selective pressure on the
nef gene. To address this question, we compared the
evolution of the MA nef gene, of the tissue culture-
adapted clone 8 nef gene, and of the deleted nef gene in
culture. AA2CL5 cells were infected with supernatants of
293 cells that had been transfected with the respective
constructs. The viruses grew with comparable kinetics
as determined by core antigen capture assay and re-
verse transcriptase activity measurements (data not
shown). The first time point was taken after 3 weeks, by
which time the cells were maximally infected, and further
samples were analyzed at 2–3-week intervals. Proviral
nef sequences were amplified in a single round, cloned,
and sequenced. As shown in Figure 4A, MA nef genes
showed a higher divergence from the input sequence,
and a higher proportion of the changes were nonsynony-
mous and resulted in stop codons, indicating selective
pressure on the gene. At the first time point, one of the
two clones obtained from the clone 8-MA nef-infected
culture contained a premature stop codon in nef. This
mutant persisted in the culture and was found again in a
clone from week 7. Similarly, a nonsense mutation found
first at week 5 was again isolated in the week 9 sample.
At week 5, one in four genes were inactivated; at week 7,
two in four; and at week 9, three in four. Overall, 39
nucleotide exchanges were observed in 14 sequences,
which resulted in 31 differences at the amino acid level,
including seven premature stop codons. In contrast, 14
proviral nef sequences isolated from an AA2CL5 culture
infected with clone 8 in the same manner showed only 13
nucleotide changes that resulted in seven nonsynony-
mous substitutions, including one premature stop codon
(Fig. 4B). Even fewer changes were observed in a culture
of AA2CL5 cells infected with clone 8 Dnef: seven nu-
cleotide substitutions resulting in four amino acid differ-
ences were observed in 11 sequences isolated over the
same time course (Fig. 4C). The ratio of nonsynonymous
to synonymous exchanges and the frequency of stop
codons seen in the clone 8 Dnef- and nef-derived se-
quences are those expected for randomly drifting se-
quences, whereas the pattern of changes found in MA
nef indicates selective pressure.
DISCUSSION
We compared DNA and predicted amino acid se-
quences for the nef genes obtained from seven animals
that had been infected with virus that had been cloned
biologically (SIVMne C1E11S) or molecularly (SIVMne
Cl8). We found random and transient changes up to 4
weeks p.i., whereas by week 8, the isoleucine at position
111 in clone 8-Nef was consistently changed to methio-
nine. This substitution was maintained in all late isolates
in addition to two other substitutions that arose consis-
tently: E34G and I87M. The substitution M153I/V was
seen in all except one, and N95D was seen in all except
two animals. Several other changes were present in at
least two animals. The nef gene sequences obtained
early from an animal that had been infected with un-
cloned virus showed only the residues at these positions
acquired late in infection in animals inoculated with
cloned virus.
A comparison of the clone 8 sequence to a consensus
sequence derived by aligning several SIVsm/HIV-2 Nef
sequences reveals that clone 8 diverges from the con-
sensus at 39 positions (see Fig. 2). Thirteen of the sub-
stitutions repeatedly found in the late isolates reconsti-
tuted the SIV/Mne Nef to the consensus sequence. Only
four substitutions occurred in more than one animal,
which involved residues that did not diverge from the
consensus sequence. This finding suggests that the
clone 8 sequence had accumulated attenuating muta-
tions during in vitro passages that were reversed in vivo.
Three of the five common substitutions would be con-
sidered conservative and involve changes from methio-
nine to isoleucine, or vice versa, and are consequences
of transitions. Nevertheless, they involve residues that
are highly conserved among SIV/Sm and derivative
strains; the methionine at position 111, which is the
earliest consistent “reversion,” aligns with a consensus
methionine in Nef proteins of all primate immunodefi-
ciency viruses (Zhu et al., 1993).
Three (N95D, I111M, and M153I) of the five most com-
mon substitutions occurred in the Nef highly conserved
core sequence. The HIV Nef core structure was recently
determined by NMR analysis (Grzesiek et al., 1996, 1997)
and, bound to the SH3 domain of Src family kinase Fyn,
by x-ray crystallography (Lee et al., 1996). The residue
corresponding to 95D lies outside the area that could be
crystallized. Residues 111 and 153 correspond to resi-
dues 79M and 121F of HIV-1 Nef, which are juxtaposed in
the tertiary structure. They define one edge of the face of
the molecule that interacts with Fyn, and the methionine
TABLE 2
Infectivity of Clone 8 and Clone 8-MA nef on SMAGI Cells
Virus strain
b-Gal.-positive cells/fielda
Experiment 1 Experiment 2
Clone 8 5 44
Clone 8 MA nef 15 110
Clone 8 Dnef 5 20
Note. Virus stocks used in the experiment were titered by antigen
capture assay. In the first experiment, virus equivalent to 9000 pg of p26
was used; in the second, to 200,000 pg. The background in both
experiments was approximately two stained cells per field.
a Average of three fields were counted.
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is considered essential for maintaining the structural
integrity of this region (Lee et al., 1996) Modeling of the
SIV/Mne Nef sequence via the SWISS Model routine
according to the coordinates of the NMR structure re-
veals that residues 111 and 153 are opposite each other
in the three-dimensional structure. However, this pro-
gram did not identify any disruption in the structure when
the residues at these positions did not match the con-
sensus.
Although no prior study has evaluated the fate of the
nef gene of a cloned provirus in this many animals, Zhu
et al. (1996) investigated Nef changes in different tissues
of three animals that had been infected with SIV/mac239.
They showed that in addition to reversion of the stop
codon that occurred in all animals, several residues
showed consistent substitutions in two of three animals.
Interestingly, none of these occurred at positions at
which the mac239 Nef diverges from a consensus Nef. A
possible explanation for this different pattern is that the
mac239 nef was completely inactivated early during
propagation in tissue culture by nonsense mutation and
did not need to acquire further attenuating mutations.
FIG. 4. Alignments of Nef sequences derived from AA2CL5 cells infected with clone 8 (A), clone 8-MA nef (B), and clone 8-nef (C). The predicted
amino acid sequences in each group are compared with the input sequences. Only divergences are shown. (Dots) Identities.
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The results of our experiment in which we analyzed
mutations that accumulate in nef genes in a trans-
formed cell line support this notion. After growth in
culture, cells infected with an SIV construct with the
MA nef gene harbored a high proportion of proviruses
(50%) with overtly inactivated nef genes. In contrast,
proviruses with clone 8 nef or with a nef gene inacti-
vated by deletion showed very few changes compared
with the input virus sequence. Although none of the
changes observed in the MA nef gene exactly recapit-
ulated those seen in the original clone 8 sequence, the
glutamic acid–to–lysine exchange at position 92 was
seen in two isolates. This change results in the dis-
ruption of a conserved acidic motif similar to the
asparagine residue in clone 8 at position 95 that is
consistently replaced by aspartic acid in vivo. Because
mutations occur randomly, it is not likely that the clone
8 gene configuration would be found again consider-
ing the many positions one would expect to contribute
to functionality, either directly by interaction with other
cell components or by supplying the structural frame-
work of the protein. Substitutions at any of these
positions singly or in combination would attenuate Nef
function. These findings show that selection in the
FIG. 4—Continued
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tissue culture environment favors cells carrying provi-
rus with a nef gene that is less functional in vivo.
This study has highlighted five residues in Nef that are
important to its function. Although the MA nef has about
the same activity for CD4 downregulation, it conferred
3-fold higher infectivity to the clone 8 virus. It is known
that animals inoculated with uncloned virus have a
shorter life expectancy than those infected with cloned
virus (R. Benveniste, et al., manuscript in preparation). It
also is noteworthy that the two animals in this study that
were infected with virus without the attenuating muta-
tions in nef developed aggressive lymphosarcoma. The
original SIV/Mne isolate was obtained from an animal
with lymphosarcoma. Although several lines of data sug-
gest that Nef is a major contributor to pathogenicity, it is
not likely that the increased virulence of the in vivo
passaged virus can be entirely attributed to the changes
in nef. Several other genes have been shown to undergo
consistent mutations in vivo, such as the reversion of the
nonsense codon in TM. Analysis of the env sequences
from the animals that had been infected with clone 8
virus showed several consistent substitutions (Rudensey
et al., 1995; Overbaugh et al., 1991). The effects of the
changes on other Nef functions that can be assayed in
vitro, such as protein interactions and effects on signal
transduction, as well as the contribution of the tissue
culture attenuated and in vivo reverted Nef to the patho-
genicity of SIV/Mne, are currently under investigation.
MATERIAL AND METHODS
Molecular cloning, restriction, and sequence analysis
of SIV/Mne proviral sequences
High-molecular-weight SIV/Mne E11S DNA (500 mg)
was partially digested with restriction endonuclease
MboI. Fragments of 12–20 kb were isolated on 10–40%
sucrose gradients in 100 mM NaCl, 10 mM Tris, pH 8, 1
mM EDTA and ligated to lEMBL3 arms generated with
BamHI (Stratagene, La Jolla, CA). After in vitro packaging
into lambda particles according to the supplier’s (Strata-
gene) protocol, 106 plaque forming units (pfu) were
plated on E. coli K802 (Sambrook et al., 1989) and
screened with radiolabeled SIV/mac DNA (108 cpm/mg).
Positive plaques were purified to homogeneity and
lambda DNA was purified using lambdasorb (Promega,
Madison, WI). Restriction digests and Southern blotting
were done following standard protocols (Sambrook et al.,
FIG. 4—Continued
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1989). DNA sequencing was done using shotgun (Mess-
ing et al., 1981) or primer directed sequencing.
Generation of recombinant virus stocks
To obtain virus from clone 8, lambda DNA was trans-
fected directly into HuT 78 cells using DEAE dextran. To
reconstitute provirus 3/9, the SalI--SacI fragments from
lambda clones 3 and 9 representing the 59 and 39 halves
of the provirus were subcloned into pZero2 (InVitrogen,
Carlsbad, California). DNAs from both plasmids were cut
with SacI and ligated before transfection into 293 cells.
To obtain clone 8-MA nef virus, two plasmids of clone 8
were generated: one (59-end plasmid) contained a 10-kb
fragment extending from a BsiWI site in the lambda
vector to the XhoI site in the nef gene (Fig. 1). The other
(39-end plasmid) contained a fragment extending from a
ScaI site just 59 of the nef gene to an XbaI site in the
genomic DNA flanking the 39 side of the provirus. BglII
and EcoNI sites unique to the 39-end plasmid were used
to exchange the nef gene sequences.
To recombine the 59- and 39-end plasmids, both were
cut at a unique BsmBI site that is just 59 of the BglII site
and is present on both plasmids and were ligated. Sim-
ilar approaches were used to generate clone 8 Dnef and
a control stock of clone 8 for this experiment. Superna-
tants of 293 cells were used to infect lymphocyte lines to
obtain virus stocks for further experiments.
Animals used in the study
Macaques used in this study were housed at the
Washington Regional Primate Research Center, which is
accredited by the American Association for Accreditation
of Laboratory Animal Care. Animals were anesthetized
with ketamine before all inoculations and blood draws.
Table 1 lists the macaques used in this study by species,
dates and identity of virus inoculation, time of sampling,
onset of CD4 depletion, and principal clinical findings at
the time of death.
PCR amplification and nucleotide sequencing of nef
sequences
Total cellular DNA was extracted from 1–5 3 106 PBLs
according to standard protocol (Higuchi, 1989). Nested PCR
was performed starting with 500 ng of DNA. The first primer
pair (59-GAGGTACACTACTGGTGGCACCTCA-39 and 59-
CTGTTCTCCCTTTGATCGAC-39) amplified the region be-
tween residues 7616 and 9372 of SIV/Mne. Two different
primer pairs were used for the second reaction. The first
set, 59-CTTGACTTGGTTATTCAGCAACTGCAG-39 and 59-
GGAATTCCTGTTCTCCCTTTGATCGAC-39, was used on
samples from animals 89152, 90076, and 91419 and am-
plified residues 8420–9372, adding an EcoRI site to the
39-end of the fragment. PCR products were cloned in
Bluescript KS (Stratagene, La Jolla, California) after
EcoRI–PstI digest. The second pair (59-CACGACCCTA-
CAGAGAATCCGAGAAG-39 and 59-ATTTTTACCGACTGT-
TCTCCCTTTGA-39) was used for samples from animals
89144, 90125, 90184, 92170, 92176, 87004, and 87047 and
amplified fragments between nucleotides 8495 and
9336, which were cloned via TA cloning into pCRII (In-
Vitrogen). The nef genes from cell culture lines were
amplified in a single PCR using 59-CTTGACTTGGTTAT-
TCAGCAACTGCAG-39 and 59-CCCATGACAGCCCTTATG-
GAAAGTC-39 primers. All reactions were carried out in
100 ml of 20 mM Tris–HCl (pH 8.4), 50 mM KCl, 1.5 mM
MgCl2, 200 mM concentration of each dNTP (Life Tech-
nologies, Gaithersburg, Maryland), 0.5 mM concentration
of each primer, and 1.25 units of Taq polymerase (Life
Technologies). Reactions were overlaid with 100 ml of
mineral oil (Life Technologies) and amplified using a
thermal cycler (Perkin-Elmer, Foster City, California). The
program consisted of 30 s at 95°C; 40 cycles of 1 min at
95°C, 1 min at 55°C, 3 min at 72°C; and 7 min at 72°C.
Fragments were cloned as indicated above. We obtained
at least two independent clones from all samples. Se-
quencing was performed using T7 and M13 primers, as
well as an internal primer that hybridized to residues
9090–9110. Sequences were assembled and analyzed
with the Lasergene software package from DNASTAR
(Madison, Wisconsin). Alignments were done using the
CLUSTAL algorithm (Higgins and Sharp, 1989).
Infectivity assay
SMAGI cells were cultured and stained for b-galacto-
sidase expression as previously described (Chackerian
et al., 1995). The concentration of virus in stocks was
determined by antigen capture assay using Coulter SIV
Core Antigen assay (Coulter Corp., Miami, Florida) or as
published (Tsai et al., 1993).
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